Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation

Cited by (998)

Items 101–200 of 998

  1. Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses
    Ana‐Maria Bulau, Marcel F. Nold, Suzhao Li, Claudia A. Nold‐Petry, Michaela Fink, Ashley S. Mansell, Tobias Schwerd, Jaewoo Hong, Anna Rubartelli, Charles Anthony Dinarello et al. · 2014 · Proceedings of the National Academy of Sciences
  2. Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH
    Christian L. Horn, Amilcar L. Morales, Christopher E. Savard, Geoffrey C. Farrell, George N. Ioannou · 2021 · Hepatology Communications
  3. Mechanistic insights from inflammasome structures
    Jianing Fu, Kate Schroder, Hao Wu · 2024 · Nature reviews. Immunology
  4. Critical role for NLRP3 in necrotic death triggered by Mycobacterium tuberculosis
    Wong, Ka‐Wing, Jacobs Jr, William R. · 2011 · Cellular Microbiology
  5. Early Hyperlipidemia Promotes Endothelial Activation via a Caspase-1-Sirtuin 1 Pathway
    Ying Yin, Xinyuan Li, Xiaojin Sha, Hang Xi, Yafeng Li, Ying Shao, Jietang Mai, Anthony T. Virtue, Jahaira Lopez‐Pastrana, Shu Meng et al. · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
  6. Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets
    Guido R.Y. De Meyer, Michelle Zurek, Pauline Puylaert, Wim Martinet · 2024 · Nature Reviews Cardiology
  7. The membrane attack complex as an inflammatory trigger
    Morgan, B. Paul · 2016 · Immunobiology
  8. Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile Inflammation
    Zheng, Yue, Humphry, Melanie, Maguire, Janet J., Bennett, Martin R., Clarke, Murray C.H. · 2013 · Immunity
  9. NLRP3 Inflammasome Activation Induced by Engineered Nanomaterials
    Bingbing Sun, Xiang Wang, Zhaoxia Ji, Ruibin Li, Tian Xia · 2012 · Small
  10. Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction
    Angélique Chevriaux, Thomas Pilot, Valentin Dérangère, Harmonie Simonin, Pierre Martine, Fanny Chalmin, François Ghiringhelli, Cédric Rébé · 2020 · Frontiers in Cell and Developmental Biology
  11. The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation
    Campden, Rhiannon I., Zhang, Yifei · 2019 · Archives of Biochemistry and Biophysics
  12. NLRP3 inflammasome pathways in atherosclerosis
    Marta Baldrighi, Ziad Mallat, Xuan Li · 2017 · Atherosclerosis
  13. NOD-like receptors and the innate immune system: Coping with danger, damage and death
    Kristof Kersse, Mathieu J.M. Bertrand, Mohamed Lamkanfi, Peter Vandenabeele · 2011 · Cytokine & Growth Factor Reviews
  14. NLRP3 Inflammasome as a Novel Player in Myocardial Infarction
    Masafumi Takahashi · 2014 · International Heart Journal
  15. Innate sensors of pathogen and stress: Linking inflammation to obesity
    Chengcheng Jin, Richard Anthony Flavell · 2013 · Journal of Allergy and Clinical Immunology
  16. Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
    Aikaterini Arida, Athanase D. Protogerou, George D. Kitas, Petros Paul Sfikakis · 2018 · International Journal of Molecular Sciences
  17. Liver X Receptors in Atherosclerosis and Inflammation
    Seung‐Soon Im, Timothy F. Osborne · 2011 · Circulation Research
  18. NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis
    Fei Yan Zheng, Shan‐Shan Xing, Zushun Gong, Qichong Xing · 2013 · Heart Lung and Circulation
  19. Inflammasome Activation by Mitochondrial Oxidative Stress in Macrophages Leads to the Development of Angiotensin II–Induced Aortic Aneurysm
    Fumitake Usui, Koumei Shirasuna, Hiroaki J. Kimura, Kazuki Tatsumi, Akira Kawashima, Tadayoshi Karasawa, Koichi Yoshimura, Hiroki Aoki, Hiroko Tsutsui, Tetsuo Noda et al. · 2014 · Arteriosclerosis Thrombosis and Vascular Biology
  20. Cholesterol Crystals and Inflammation
    Alena Grebe, Eicke Latz · 2013 · Current Rheumatology Reports
  21. NLRP3 inflammasome as a key driver of vascular disease
    Masafumi Takahashi · 2021 · Cardiovascular Research
  22. Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice
    Fumitake Usui, Koumei Shirasuna, Hiroaki J. Kimura, Kazuki Tatsumi, Akira Kawashima, Tadayoshi Karasawa, Shigeaki Hida, Junji Sagara, Shun’ichiro Taniguchi, Masafumi Takahashi · 2012 · Biochemical and Biophysical Research Communications
  23. Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice
    Nomura, Johji, Busso, Nathalie, Ives, Annette, Matsui, Chieko, Tsujimoto, Syunsuke, Shirakura, Takashi, Tamura, Mizuho, Kobayashi, Tsunefumi, So, Alexander, Yamanaka, Yoshihiro · 2014 · Scientific Reports
  24. Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH
    George N. Ioannou, Savitha Subramanian, Alan Chait, W. Geoffrey Haigh, Matthew M. Yeh, Geoffrey C. Farrell, Sum P. Lee, Christopher E. Savard · 2017 · Journal of Lipid Research
  25. Pyroptosis: A pro-inflammatory type of cell death in cardiovascular disease
    Qun Wang, Jianfeng Wu, Yicheng Zeng, Kong Chen, Chuangxin Wang, Shiqi Yang, Nisi Sun, Hao Chen, Kang Duan, Gaofeng Zeng · 2020 · Clinica Chimica Acta
  26. Anti-Inflammatory and Antiatherogenic Effects of the NLRP3 Inflammasome Inhibitor Arglabin in ApoE 2 .Ki Mice Fed a High-Fat Diet
    Amna Abderrazak, Dominique Couchie, Dler Faieeq Darweesh Mahmood, Rima Elhage, Cécile Vindis, Muriel Laffargue, Véronique Mateo, Berthold Büchele, Mónica Rubio Ayala, Menna El Gaafary et al. · 2015 · Circulation
  27. Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes
    Laurence Bessueille, David Magne · 2015 · Cellular and Molecular Life Sciences
  28. RETRACTED: Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes
    Dimitry A. Chistiakov, Yuri Veniaminovich Bobryshev, Nikita Gennadievich Nikiforov, Natalia Vladimirovna Elizova, Igor Alexandrovich Sobenin, Alexander Nikolaevich Orekhov · 2015 · International Journal of Cardiology · Retracted
  29. Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
    Allison B. Goldfine, Steven E. Shoelson · 2017 · Journal of Clinical Investigation
  30. Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats
    Qinghua Hu, Xian Zhang, Ying Pan, Yucheng Li, Ling‐Dong Kong · 2012 · Biochemical Pharmacology
  31. Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome
    Dirk Holzinger, Laura Gieldon, Vijayashree Mysore, Nadine Nippe, Debra J. Taxman, Joseph A. Duncan, Peter M. Broglie, Kristina Marketon, Judith Austermann, Thomas Vogl et al. · 2012 · Journal of Leukocyte Biology
  32. The Inflammasome in Atherosclerosis and Type 2 Diabetes
    Masters, Seth L., Latz, Eicke, O’Neill, Luke A. J. · 2011 · Science Translational Medicine
  33. Cell Death, Damage-Associated Molecular Patterns, and Sterile Inflammation in Cardiovascular Disease
    Yue Zheng, Sarah E. Gardner, Murray C.H. Clarke · 2011 · Arteriosclerosis Thrombosis and Vascular Biology
  34. Inflammation as a Therapeutic Target in Atherosclerosis
    Mau T. Nguyen, Sanuja Fernando, Nisha Schwarz, Joanne T. M. Tan, Christina A. Bursill, Peter James Psaltis · 2019 · Journal of Clinical Medicine
  35. The Biological Role of Inflammation in Atherosclerosis
    Wong, Brian W., Meredith, Anna, Lin, David, McManus, Bruce M. · 2012 · Canadian Journal of Cardiology
  36. Cytokine Circuits in Cardiovascular Disease
    Jesse W. Williams, Li-Hao Huang, Gwendalyn J. Randolph · 2019 · Immunity
  37. The immune system's involvement in obesity-driven type 2 diabetes
    Chengyi Jenny Shu, Christophe O. Benoist, Diane J. Mathis · 2012 · Seminars in Immunology
  38. Adipose Organ Development and Remodeling
    Saverio Cinti · 2018 · Comprehensive physiology
  39. Targeting inflammation to reduce cardiovascular disease risk: A realistic clinical prospect?
    Welsh, Paul, Grassia, Gianluca, Botha, Shani, Sattar, Naveed, Maffia, Pasquale · 2017 · British Journal of Pharmacology
  40. Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis
    Lin Lin, Mu-xin Zhang, Lei Zhang, Dan Zhang, Chao Li, Yunlun Li · 2022 · Frontiers in Cell and Developmental Biology
  41. The Nrf2-HO-1 system and inflammaging
    Sinead A O’Rourke, Lianne C. Shanley, Aisling Dunne · 2024 · Frontiers in Immunology
  42. Free radicals and male reproduction.
    Ashok Kumar Agarwal, Shyam S.R. Allamaneni · 2011 · PubMed
  43. Inflammasome activation and IL‐1β/IL‐18 processing are influenced by distinct pathways in microglia
    Richa Hanamsagar, Victor J. Torres, Tammy Kielian · 2011 · Journal of Neurochemistry
  44. The Inflammasome in Myocardial Injury and Cardiac Remodeling
    Stefano A Toldo, Eleonora Mezzaroma, Adolfo Gabriele Mauro, Fadi N. Salloum, Benjamin Wallace Van Tassell, Antonio Abbate · 2014 · Antioxidants and Redox Signaling
  45. Differential effects of short chain fatty acids on endothelial Nlrp3 inflammasome activation and neointima formation: Antioxidant action of butyrate
    Xinxu Yuan, Lei Wang, Owais Mohammad Bhat, Hannah Lohner, Pin‐Lan Li · 2018 · Redox Biology
  46. Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung
    Laura Rotolo, Daryll A. Vanover, Nicholas C. Bruno, Hannah E. Peck, Chiara Zurla, Jackelyn Murray, Richard K. Noel, Laura O’Farrell, Mariluz Araínga, Nichole Orr‐Burks et al. · 2022 · Nature Materials
  47. Metalloproteinase production from macrophages – a perfect storm leading to atherosclerotic plaque rupture and myocardial infarction
    Andrew C. Newby · 2016 · Experimental Physiology
  48. Curcumin Represses NLRP3 Inflammasome Activation via TLR4/MyD88/NF-κB and P2X7R Signaling in PMA-Induced Macrophages
    Fanqi Kong, Bozhi Ye, Jiatian Cao, Xueli Cai, Lin Lü, Shanjun Huang, Weijian Huang, Zhouqing Huang · 2016 · Frontiers in Pharmacology
  49. Transcriptomic Analysis of Vulvovaginal Candidiasis Identifies a Role for the NLRP3 Inflammasome
    Bruno, Vincent M., Shetty, Amol C., Yano, Junko, Fidel, Paul L., Noverr, Mairi C., Peters, Brian M. · 2015 · mBio
  50. Phenotypic modulation of macrophages in response to plaque lipids
    Adamson, Samantha, Leitinger, Norbert · 2011 · Current Opinion in Lipidology
  51. Characterization of Cholesterol Crystals in Atherosclerotic Plaques Using Stimulated Raman Scattering and Second-Harmonic Generation Microscopy
    Jeffrey L. Suhalim, Chao‐Yu Chung, Magnus Borstad Lilledahl, Ryan S. Lim, Moshe Levi, Bruce J. Tromberg, Eric Olaf Potma · 2012 · Biophysical Journal
  52. MicroRNAs in the Pathobiology and Therapy of Atherosclerosis
    Benoit Laffont, Katey J. Rayner · 2017 · Canadian Journal of Cardiology
  53. Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space
    Adam G. Schwaid, Kerrie B. Spencer · 2020 · Journal of Medicinal Chemistry
  54. Role of Nrf2 in the pathogenesis of atherosclerosis
    Junsei Mimura, Ken Itoh · 2015 · Free Radical Biology and Medicine
  55. MARK4 regulates NLRP3 positioning and inflammasome activation through a microtubule-dependent mechanism
    Xuan Li, Sarah Thome, Xiaodan Ma, Mamta Amrute‐Nayak, Alison J. Finigan, Lauren Kitt, Leanne M. Masters, John R. James, Yuguang Shi, Guoyu Meng et al. · 2017 · Nature Communications
  56. Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis
    Ying Hua Jin, Jian Fu · 2019 · Journal of the American Heart Association
  57. Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice
    Fei Yan Zheng, Shan‐Shan Xing, Zushun Gong, Wei Mu, Qichong Xing · 2014 · Mediators of Inflammation
  58. Inflammation and cardiovascular diseases: lessons from seminal clinical trials
    Luca Liberale, Fabrizio Montecucco, Lena Schwarz, Thomas Felix Lüscher, Giovanni Guido Camici · 2020 · Cardiovascular Research
  59. Moderate Hypoxia Potentiates Interleukin-1β Production in Activated Human Macrophages
    Eduardo J.E. Folco, Galina K. Sukhova, Thibaut Quillard, Peter Libby · 2014 · Circulation Research
  60. Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants
    Colleen Olive · 2012 · Expert Review of Vaccines
  61. Lipid Abnormalities and Inflammation in HIV Inflection
    Nicholas Funderburg, Nehal N. Mehta · 2016 · Current HIV/AIDS Reports
  62. Inhibiting the Inflammasome: A Chemical Perspective
    Alex G. Baldwin, David Brough, Sally Freeman · 2015 · Journal of Medicinal Chemistry
  63. Astilbin improves potassium oxonate-induced hyperuricemia and kidney injury through regulating oxidative stress and inflammation response in mice
    Ming Wang, Jing Zhao, Nan Zhang, Jianghua Chen · 2016 · Biomedicine & Pharmacotherapy
  64. Context-Dependent Role of Oxidized Lipids and Lipoproteins in Inflammation
    Yury I. Miller, John Y.-J. Shyy · 2016 · Trends in Endocrinology and Metabolism
  65. Mechanisms of NLRP3 priming in inflammaging and age related diseases
    Anna Gritsenko, Jack Green, David Brough, Gloria López‐Castejón · 2020 · Cytokine & Growth Factor Reviews
  66. Human Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses
    Ryoko Kiyotake, Masatsugu Oh‐hora, Eri Ishikawa, Tomofumi Miyamoto, Tatsuro Ishibashi, Sho Yamasaki · 2015 · Journal of Biological Chemistry
  67. NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K + efflux and Ca 2+ influx
    Michael A. Katsnelson, Kristen M. Lozada‐Soto, Hana M. Russo, Barbara A. Miller, George Dubyak · 2016 · American Journal of Physiology-Cell Physiology
  68. Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis
    Yvonne Baumer, Sara McCurdy, Tina M. Weatherby, Nehal N. Mehta, Stéfan Halbherr, Pascal Halbherr, Noboru Yamazaki, William A. Boisvert · 2017 · Nature Communications
  69. Vascular inflammation and low‐density lipoproteins: is cholesterol the link? A lesson from the clinical trials
    Alberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata · 2017 · British Journal of Pharmacology
  70. Emerging roles for cholesterol and lipoproteins in lung disease
    Kymberly M. Gowdy, Michael B. Fessler · 2012 · Pulmonary Pharmacology & Therapeutics
  71. Challenges and advances in the management of inflammation in atherosclerosis
    Yiming Xing, Xianhe Lin · 2024 · Journal of Advanced Research
  72. P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation
    Peng Kuang, Lu-Shan Liu, Dangheng Wei, Yun-Cheng Lv, Gang Wang, Wenhao Xiong, Xiaoqing Wang, Afrasyab Altaf, Lili Wang, Dan He et al. · 2015 · International Journal of Molecular Medicine
  73. High‐density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation
    Seth G. Thacker, Abdalrahman Zarzour, Ye Chen, Mustafa Selahattin Alçiçek, Lita A. Freeman, Dennis O. Sviridov, Stephen J. Demosky, Alan Thomas Remaley · 2016 · Immunology
  74. Cholesterol and Late-Life Cognitive Decline
    Peter van Vliet · 2012 · Journal of Alzheimer s Disease
  75. NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin
    Mamoru Satoh, Tsuyoshi Tabuchi, Tomonori Itoh, Motoyuki Nakamura · 2013 · Clinical Science
  76. Tissular Tregs: A unique population of adipose-tissue-resident Foxp3+CD4+ T cells that impacts organismal metabolism
    Daniela Cipolletta, Dmitriy Kolodin, Christophe O. Benoist, Diane J. Mathis · 2011 · Seminars in Immunology
  77. Double-walled carbon nanotubes trigger IL-1β release in human monocytes through Nlrp3 inflammasome activation
    Étienne Meunier, Agnès Coste, David P. Olagnier, Hélène Authier, Lise Lefèvre, Christophe Dardenne, José Bernad, Maryse Béraud, Emmanuel Flahaut B, Bernard Pipy · 2011 · Nanomedicine Nanotechnology Biology and Medicine
  78. Affinity-Driven Design of Cargo-Switching Nanoparticles to Leverage a Cholesterol-Rich Microenvironment for Atherosclerosis Therapy
    Heegon Kim, Sandeep Kumar, Dong Won Kang, Hanjoong Jo, Ji‐Ho Park · 2020 · ACS Nano
  79. Constitutively Activated NLRP3 Inflammasome Causes Inflammation and Abnormal Skeletal Development in Mice
    Sheri L. Bonar, S. Brydges, J. Mueller, Matthew D. McGeough, C. Peña, Debbie Chen, S. Grimston, Cynthia L. Hickman-Brecks, S. Ravindran, A. McAlinden et al. · 2012 · PLoS ONE
  80. Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability
    Dimitry A. Chistiakov, Alexander Nikolaevich Orekhov, Y. V. Bobryshev · 2014 · Acta Physiologica
  81. Immune cell profiling in atherosclerosis: role in research and precision medicine
    Dawn M. Fernandez, Chiara Giannarelli · 2021 · Nature Reviews Cardiology
  82. Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes
    Fanqi Kong, Bozhi Ye, Lin Lü, Xueli Cai, Weijian Huang, Zhouqing Huang · 2016 · Biomedicine & Pharmacotherapy
  83. MASH: the nexus of metabolism, inflammation, and fibrosis
    Gregory R. Steinberg, André C. Carpentier, Dongdong Wang · 2025 · Journal of Clinical Investigation
  84. Red blood cell, hemoglobin and heme in the progression of atherosclerosis
    Viktória Jeney, György Jázon Balla, József Balla · 2014 · Frontiers in Physiology
  85. Mitochondria, the NLRP3 Inflammasome, and Sirtuins in Type 2 Diabetes: New Therapeutic TargetsReviewing Editors: Markus Bachschmid, Dylan Burger, Vittorio Calabrese, Amadou Camara, Lukas Kubala, Giuseppe Poli, and Chandan K. Sen
    Susana Rovira‐Llopis, Nadezda Apostolova, Celia Bañuls, Jordi Muntané, Milagros Rocha, Víctor M. Víctor · 2017 · Antioxidants and Redox Signaling
  86. Increasing both CoCrMo‐alloy particle size and surface irregularity induces increased macrophage inflammasome activation in vitro potentially through lysosomal destabilization mechanisms
    Marco S. Caicedo, Lauryn Samelko, Kyron McAllister, Joshua James Jacobs, Nadim James Hallab · 2013 · Journal of Orthopaedic Research®
  87. Role of Vascular Inflammation in Coronary Artery Disease: Potential of Anti-inflammatory Drugs in the Prevention of Atherothrombosis
    Daniel Medeiros Moreira, Roberto Léo da Silva, Jefferson Luís Vieira, Tammuz Fattah, Maria Emília Lueneberg, Carlos Antônio Mascia Gottschall · 2014 · American Journal of Cardiovascular Drugs
  88. From Inflammasome to Exosome—Does Extracellular Vesicle Secretion Constitute an Inflammasome-Dependent Immune Response?
    Wojciech Cypryk, Tuula A. Nyman, Sampsa Matikainen · 2018 · Frontiers in Immunology
  89. Inflammasomes and Metabolic Disorders: Old Genes in Modern Diseases
    Gregory R. Robbins, Haitao Wen, Jenny P.‐Y. Ting · 2014 · Molecular Cell
  90. Role and function of macrophages in the metabolic syndrome
    Prerna Bhargava, Chih‐Hao Lee · 2012 · Biochemical Journal
  91. This old heart: Cardiac aging and autophagy
    Phyllis‐Jean Linton, Michael A. Gurney, David M. Sengstock, Robert M. Mentzer, Roberta A. Gottlieb · 2014 · Journal of Molecular and Cellular Cardiology
  92. Hyperlipidemia and Atherosclerotic Lesion Development in Ldlr-Deficient Mice on a Long-Term High-Fat Diet
    Yanling Ma, Wenyi Wang, Jie Zhang, Youli Lu, Wenyu Wu, Hong Yan, Yiping Wang · 2012 · PLoS ONE
  93. Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis
    María Luna‐Luna, Aída Xochitl Medina-Urrutia, Gilberto Vargas‐Alarcón, Fernanda Coss-Rovirosa, Jesús Vargas‐Barrón, Oscar A Pérez-Méndez · 2015 · Archives of Medical Research
  94. MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1/STAT Signaling Pathway
    Yue Wang, Zhihua Han, Yuqi Fan, Junfeng Zhang, Kan Chen, Lin Gao, Huasu Zeng, Jiatian Cao, Changqian Wang · 2017 · Cellular Physiology and Biochemistry
  95. Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction
    Max J. M. Silvis, Evelyne J. Demkes, Aernoud T.L. Fiolet, Mirthe Dekker, Lena Bosch, Gerardus P. J. van Hout, Leo Timmers, Dominique P.V. de Kleijn · 2020 · Journal of Cardiovascular Translational Research
  96. Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging
    Ryan S. Lim, Jeffrey L. Suhalim, Shinobu Miyazaki‐Anzai, Makoto Miyazaki, Moshe Levi, Eric Olaf Potma, Bruce J. Tromberg · 2011 · Journal of Lipid Research
  97. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis
    Jan Hettwer, Julia Hinterdobler, Benedikt Miritsch, Marcus-André Deutsch, Xinghai Li, Carina Mauersberger, Aldo Moggio, Quinte Braster, Hermann Gram, Avril A. B. Robertson et al. · 2021 · Cardiovascular Research
  98. The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis
    Anders Hovland, Lena Jonasson, Peter Garred, Arne Yndestad, Pål Aukrust, Knut Tore Lappegård, Terje Espevik, Tom Eirik Mollnes · 2015 · Atherosclerosis
  99. Self-eating in the plaque: what macrophage autophagy reveals about atherosclerosis
    Ismail Sergin, Babak Razani · 2014 · Trends in Endocrinology and Metabolism
  100. Label‐Free Quantitative Imaging of Cholesterol in Intact Tissues by Hyperspectral Stimulated Raman Scattering Microscopy
    Ping Wang, Junjie Li, Pu Wang, Chunrui Hu, Delong Zhang, Michael S. Sturek, Ji‐Xin Cheng · 2013 · Angewandte Chemie International Edition